Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Effect of extradural constriction on CSF flow in rat spinal cord.

Berliner JA, Woodcock T, Najafi E, Hemley SJ, Lam M, Cheng S, Bilston LE, Stoodley MA.

Fluids Barriers CNS. 2019 Mar 26;16(1):7. doi: 10.1186/s12987-019-0127-8.

2.

Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis.

Kim S, Graham MJ, Lee RG, Yang L, Kim S, Subramanian V, Layne JD, Cai L, Temel RE, Shih D, Lusis AJ, Berliner JA, Lee S.

Nutr Metab Cardiovasc Dis. 2019 Mar;29(3):306-315. doi: 10.1016/j.numecd.2018.12.006. Epub 2019 Jan 9.

PMID:
30738642
3.

Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.

Kim S, Yang L, Kim S, Lee RG, Graham MJ, Berliner JA, Lusis AJ, Cai L, Temel RE, Rateri DL, Lee S.

PLoS One. 2017 Aug 9;12(8):e0182566. doi: 10.1371/journal.pone.0182566. eCollection 2017.

4.

Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis.

Briot A, Civelek M, Seki A, Hoi K, Mack JJ, Lee SD, Kim J, Hong C, Yu J, Fishbein GA, Vakili L, Fogelman AM, Fishbein MC, Lusis AJ, Tontonoz P, Navab M, Berliner JA, Iruela-Arispe ML.

J Exp Med. 2015 Nov 16;212(12):2147-63. doi: 10.1084/jem.20150603. Epub 2015 Nov 9.

5.

Regulation of NF-κB signaling by oxidized glycerophospholipid and IL-1β induced miRs-21-3p and -27a-5p in human aortic endothelial cells.

Romay MC, Che N, Becker SN, Pouldar D, Hagopian R, Xiao X, Lusis AJ, Berliner JA, Civelek M.

J Lipid Res. 2015 Jan;56(1):38-50. doi: 10.1194/jlr.M052670. Epub 2014 Oct 19.

6.

HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanisms.

Emert B, Hasin-Brumshtein Y, Springstead JR, Vakili L, Berliner JA, Lusis AJ.

J Lipid Res. 2014 Aug;55(8):1678-92. doi: 10.1194/jlr.M047738. Epub 2014 May 23.

7.

An epoxyisoprostane is a major regulator of endothelial cell function.

Zhong W, Springstead JR, Al-Mubarak R, Lee S, Li R, Emert B, Berliner JA, Jung ME.

J Med Chem. 2013 Nov 14;56(21):8521-32. doi: 10.1021/jm400959q. Epub 2013 Oct 31.

8.

Identification of CAD candidate genes in GWAS loci and their expression in vascular cells.

Erbilgin A, Civelek M, Romanoski CE, Pan C, Hagopian R, Berliner JA, Lusis AJ.

J Lipid Res. 2013 Jul;54(7):1894-905. doi: 10.1194/jlr.M037085. Epub 2013 May 10.

9.

Phosphoproteomic analysis of aortic endothelial cells activated by oxidized phospholipids.

Zimman A, Berliner JA, Graeber TG.

Methods Mol Biol. 2013;1000:53-69. doi: 10.1007/978-1-62703-405-0_5.

PMID:
23585084
10.

Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC.

Birukova AA, Starosta V, Tian X, Higginbotham K, Koroniak L, Berliner JA, Birukov KG.

Transl Res. 2013 Jun;161(6):495-504. doi: 10.1016/j.trsl.2012.12.008. Epub 2013 Jan 8.

11.

Role of phospholipid oxidation products in atherosclerosis.

Lee S, Birukov KG, Romanoski CE, Springstead JR, Lusis AJ, Berliner JA.

Circ Res. 2012 Aug 31;111(6):778-99. doi: 10.1161/CIRCRESAHA.111.256859. Review.

12.

Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function.

Springstead JR, Gugiu BG, Lee S, Cha S, Watson AD, Berliner JA.

J Lipid Res. 2012 Jul;53(7):1304-15. doi: 10.1194/jlr.M025320. Epub 2012 May 1.

13.

Metalloproteinase processing of HBEGF is a proximal event in the response of human aortic endothelial cells to oxidized phospholipids.

Lee S, Springstead JR, Parks BW, Romanoski CE, Palvolgyi R, Ho T, Nguyen P, Lusis AJ, Berliner JA.

Arterioscler Thromb Vasc Biol. 2012 May;32(5):1246-54. doi: 10.1161/ATVBAHA.111.241257. Epub 2012 Mar 8.

14.

A role for VEGFR2 activation in endothelial responses caused by barrier disruptive OxPAPC concentrations.

Birukova AA, Lee S, Starosta V, Wu T, Ho T, Kim J, Berliner JA, Birukov KG.

PLoS One. 2012;7(1):e30957. doi: 10.1371/journal.pone.0030957. Epub 2012 Jan 31.

15.

Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine.

Starosta V, Wu T, Zimman A, Pham D, Tian X, Oskolkova O, Bochkov V, Berliner JA, Birukova AA, Birukov KG.

Am J Respir Cell Mol Biol. 2012 Mar;46(3):331-41. doi: 10.1165/rcmb.2011-0153OC. Epub 2011 Oct 13.

16.

Paraoxonase-2 modulates stress response of endothelial cells to oxidized phospholipids and a bacterial quorum-sensing molecule.

Kim JB, Xia YR, Romanoski CE, Lee S, Meng Y, Shi YS, Bourquard N, Gong KW, Port Z, Grijalva V, Reddy ST, Berliner JA, Lusis AJ, Shih DM.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2624-33. doi: 10.1161/ATVBAHA.111.232827.

17.

Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1.

Romanoski CE, Che N, Yin F, Mai N, Pouldar D, Civelek M, Pan C, Lee S, Vakili L, Yang WP, Kayne P, Mungrue IN, Araujo JA, Berliner JA, Lusis AJ.

Circ Res. 2011 Aug 19;109(5):e27-41. doi: 10.1161/CIRCRESAHA.111.241869. Epub 2011 Jul 7.

18.

Activation of aortic endothelial cells by oxidized phospholipids: a phosphoproteomic analysis.

Zimman A, Chen SS, Komisopoulou E, Titz B, Martínez-Pinna R, Kafi A, Berliner JA, Graeber TG.

J Proteome Res. 2010 Jun 4;9(6):2812-24. doi: 10.1021/pr901194x.

19.

Systems genetics analysis of gene-by-environment interactions in human cells.

Romanoski CE, Lee S, Kim MJ, Ingram-Drake L, Plaisier CL, Yordanova R, Tilford C, Guan B, He A, Gargalovic PS, Kirchgessner TG, Berliner JA, Lusis AJ.

Am J Hum Genet. 2010 Mar 12;86(3):399-410. doi: 10.1016/j.ajhg.2010.02.002. Epub 2010 Feb 18.

20.

Oxidized low-density lipoprotein-activated c-Jun NH2-terminal kinase regulates manganese superoxide dismutase ubiquitination: implication for mitochondrial redox status and apoptosis.

Takabe W, Li R, Ai L, Yu F, Berliner JA, Hsiai TK.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):436-41. doi: 10.1161/ATVBAHA.109.202135. Epub 2010 Feb 5.

21.

A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids.

Lee S, Gharavi NM, Honda H, Chang I, Kim B, Jen N, Li R, Zimman A, Berliner JA.

Free Radic Biol Med. 2009 Jul 15;47(2):145-51. doi: 10.1016/j.freeradbiomed.2009.04.013. Epub 2009 Apr 16.

22.

The role of oxidized phospholipids in atherosclerosis.

Berliner JA, Leitinger N, Tsimikas S.

J Lipid Res. 2009 Apr;50 Suppl:S207-12. doi: 10.1194/jlr.R800074-JLR200. Epub 2008 Dec 4.

23.

Ox-PAPC activation of PMET system increases expression of heme oxygenase-1 in human aortic endothelial cell.

Lee S, Li R, Kim B, Palvolgyi R, Ho T, Yang QZ, Xu J, Szeto WL, Honda H, Berliner JA.

J Lipid Res. 2009 Feb;50(2):265-74. doi: 10.1194/jlr.M800317-JLR200. Epub 2008 Aug 29.

24.

Improved synthesis of the epoxy isoprostane phospholipid PEIPC and its reactivity with amines.

Jung ME, Berliner JA, Koroniak L, Gugiu BG, Watson AD.

Org Lett. 2008 Oct 2;10(19):4207-9. doi: 10.1021/ol8014804. Epub 2008 Aug 28.

25.

Endothelial cell regulation by phospholipid oxidation products.

Berliner JA, Gharavi NM.

Free Radic Biol Med. 2008 Jul 15;45(2):119-23. doi: 10.1016/j.freeradbiomed.2008.04.013. Epub 2008 Apr 20. Review.

26.

Oxidative stress as a regulator of murine atherosclerosis.

Hsiai T, Berliner JA.

Curr Drug Targets. 2007 Dec;8(12):1222-9. Review.

PMID:
18220699
27.

Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo.

Gharavi NM, Alva JA, Mouillesseaux KP, Lai C, Yeh M, Yeung W, Johnson J, Szeto WL, Hong L, Fishbein M, Wei L, Pfeffer LM, Berliner JA.

J Biol Chem. 2007 Oct 26;282(43):31460-8. Epub 2007 Aug 28.

28.

Future of toxicology--lipidomics, an important emerging area for toxicologists: focus on lipid oxidation products.

Berliner JA, Zimman A.

Chem Res Toxicol. 2007 Jun;20(6):849-53. Epub 2007 May 10. Review. No abstract available.

PMID:
17489606
29.

High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.

Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark MJ, Szeto WL, Watson AD, Lusis AJ, Berliner JA.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1346-53. Epub 2007 Mar 22.

PMID:
17379837
30.

OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids.

Li R, Chen W, Yanes R, Lee S, Berliner JA.

J Lipid Res. 2007 Mar;48(3):709-15. Epub 2006 Dec 27.

31.

Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids.

Zimman A, Mouillesseaux KP, Le T, Gharavi NM, Ryvkin A, Graeber TG, Chen TT, Watson AD, Berliner JA.

Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):332-8. Epub 2006 Nov 16.

PMID:
17110601
32.

The unfolded protein response is an important regulator of inflammatory genes in endothelial cells.

Gargalovic PS, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Baruch-Oren T, Berliner JA, Kirchgessner TG, Lusis AJ.

Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2490-6. Epub 2006 Aug 24.

PMID:
16931790
33.

Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids.

Gargalovic PS, Imura M, Zhang B, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Patel S, Nelson SF, Horvath S, Berliner JA, Kirchgessner TG, Lusis AJ.

Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12741-6. Epub 2006 Aug 15.

34.

A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products.

Walton KA, Gugiu BG, Thomas M, Basseri RJ, Eliav DR, Salomon RG, Berliner JA.

J Lipid Res. 2006 Sep;47(9):1967-74. Epub 2006 Jun 14.

35.

Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids.

Gharavi NM, Baker NA, Mouillesseaux KP, Yeung W, Honda HM, Hsieh X, Yeh M, Smart EJ, Berliner JA.

Circ Res. 2006 Mar 31;98(6):768-76. Epub 2006 Feb 23.

PMID:
16497987
36.

Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase.

Huber J, Fürnkranz A, Bochkov VN, Patricia MK, Lee H, Hedrick CC, Berliner JA, Binder BR, Leitinger N.

J Lipid Res. 2006 May;47(5):1054-62. Epub 2006 Feb 5.

37.

Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC.

Li R, Mouillesseaux KP, Montoya D, Cruz D, Gharavi N, Dun M, Koroniak L, Berliner JA.

Circ Res. 2006 Mar 17;98(5):642-50. Epub 2006 Feb 2.

PMID:
16456101
38.

Total synthesis of the epoxy isoprostane phospholipids PEIPC and PECPC.

Jung ME, Berliner JA, Angst D, Yue D, Koroniak L, Watson AD, Li R.

Org Lett. 2005 Sep 1;7(18):3933-5.

PMID:
16119935
39.

A role for oxidized phospholipids in atherosclerosis.

Berliner JA, Watson AD.

N Engl J Med. 2005 Jul 7;353(1):9-11. No abstract available. Erratum in: N Engl J Med. 2005 Oct 27;353(17):1869.

PMID:
16000351
40.

Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory.

Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, Witztum JL.

J Exp Med. 2004 Dec 6;200(11):1359-70.

41.

Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products.

Yeh M, Cole AL, Choi J, Liu Y, Tulchinsky D, Qiao JH, Fishbein MC, Dooley AN, Hovnanian T, Mouilleseaux K, Vora DK, Yang WP, Gargalovic P, Kirchgessner T, Shyy JY, Berliner JA.

Circ Res. 2004 Oct 15;95(8):780-8. Epub 2004 Sep 23.

PMID:
15388640
42.
43.

Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway.

Yeh M, Gharavi NM, Choi J, Hsieh X, Reed E, Mouillesseaux KP, Cole AL, Reddy ST, Berliner JA.

J Biol Chem. 2004 Jul 16;279(29):30175-81. Epub 2004 May 13.

44.

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM.

J Lipid Res. 2004 Jun;45(6):993-1007. Epub 2004 Apr 1. Review.

45.

Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.

Yun JJ, Whiting D, Fischbein MP, Banerji A, Irie Y, Stein D, Fishbein MC, Proudfoot AE, Laks H, Berliner JA, Ardehali A.

Circulation. 2004 Feb 24;109(7):932-7. Epub 2004 Feb 2.

PMID:
14757698
46.

Minimally oxidized low-density lipoprotein regulates hemostasis factors of brain capillary endothelial cells.

Kim JA, Tran ND, Berliner JA, Fisher MJ.

J Neurol Sci. 2004 Feb 15;217(2):135-41.

PMID:
14706215
47.

Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway.

Cole AL, Subbanagounder G, Mukhopadhyay S, Berliner JA, Vora DK.

Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1384-90. Epub 2003 Jun 12.

PMID:
12805072
48.
49.

Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2.

Walton KA, Cole AL, Yeh M, Subbanagounder G, Krutzik SR, Modlin RL, Lucas RM, Nakai J, Smart EJ, Vora DK, Berliner JA.

Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1197-203. Epub 2003 May 29.

PMID:
12775576
50.

Glucose regulates monocyte adhesion through endothelial production of interleukin-8.

Srinivasan S, Yeh M, Danziger EC, Hatley ME, Riggan AE, Leitinger N, Berliner JA, Hedrick CC.

Circ Res. 2003 Mar 7;92(4):371-7. Epub 2003 Feb 13.

PMID:
12600878

Supplemental Content

Loading ...
Support Center